Although T2DM may also develop independently through impaired insulin secretion or in combination with insulin resistance, current experimental guidelines recommend initial induction of insulin resistance via HFD, followed by low-dose STZ (20–35 mg/kg, IV or IP) to partially impair pancreatic β-cell function (Ghasemi & Jeddi, 2023). This evidence concerns the gene INS and Insulin resistance.